Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.

作者: Marcel Levi

DOI: 10.1016/J.THROMRES.2018.01.016

关键词: MedicineDisseminated intravascular coagulationSepsisFulminantClotting factorThrombotic microangiopathyGastroenterologyInternal medicineThrombosisFibrinolysisFibrin

摘要: Malignant disease can be complicated by disseminated intravascular coagulation (DIC). DIC is defined as systemic triggering of (resulting in fibrin clot formation) and concurrent depletion clotting factors platelets (increasing the risk hemorrhage). The clinical presentation patients with cancer has usually a less fulminant than that may accompany other underlying disorders, such sepsis trauma. A more insidious, but also protracted, diffuse activation proceed without any symptom. Ultimately this lead to deficiency hemorrhage (often at site tumor or metastases) first symptom indicating presence DIC. An alternative thrombosis, ranging from overt venous thrombo-embolism microvascular thrombotic microangiopathy. therapeutic foundation management condition some cases supportive interventions, specifically targeting hemostatic system needed.

参考文章(75)
Maria Benedetta Donati, Cancer and thrombosis : from Phlegmasia Alba Dolens to transgenic mice Thrombosis and Haemostasis. ,vol. 74, pp. 278- 281 ,(1995) , 10.1055/S-0038-1642690
Donald I Feinstein, Disseminated intravascular coagulation in patients with solid tumors. Oncology. ,vol. 29, pp. 96- 102 ,(2015)
Andrew Pettitt, Richard Clark, Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplantation. ,vol. 14, pp. 495- 504 ,(1994)
T. M. H. NIERS, M. DI NISIO, C. P. W. KLERK, H. J. BAARSLAG, H. R. BÜLLER, B. J. BIEMOND, Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 1878- 1882 ,(2007) , 10.1111/J.1538-7836.2007.02660.X
SN Rabinowe, RJ Soiffer, NJ Tarbell, D Neuberg, AS Freedman, J Seifter, KW Blake, JG Gribben, KC Anderson, T Takvorian, Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood. ,vol. 77, pp. 1837- 1844 ,(1991) , 10.1182/BLOOD.V77.8.1837.1837
EC Guinan, NJ Tarbell, CM Niemeyer, SE Sallan, HJ Weinstein, Intravascular hemolysis and renal insufficiency after bone marrow transplantation Blood. ,vol. 72, pp. 451- 455 ,(1988) , 10.1182/BLOOD.V72.2.451.451
Marcel Levi, Steven M Opal, Coagulation abnormalities in critically ill patients. Critical Care. ,vol. 10, pp. 222- 222 ,(2006) , 10.1186/CC4975
AH Sarris, S Kempin, E Berman, J Michaeli, C Little, M Andreeff, T Gee, D Straus, B Gansbacher, D Filippa, High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. ,vol. 79, pp. 1305- 1310 ,(1992) , 10.1182/BLOOD.V79.5.1305.1305
H. SAITO, I. MARUYAMA, S. SHIMAZAKI, Y. YAMAMOTO, N. AIKAWA, R. OHNO, A. HIRAYAMA, T. MATSUDA, H. ASAKURA, M. NAKASHIMA, N. AOKI, Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 31- 41 ,(2007) , 10.1111/J.1538-7836.2006.02267.X
Mark N Levine, Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thrombosis and Haemostasis. ,vol. 78, pp. 133- 136 ,(1997) , 10.1055/S-0038-1657515